Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

QUOTED. 30 October 2020. Dan Buehner.

Executive Summary

Edwards Lifesciences has slashed the number of open CAPAs at its Draper, UT, manufacturing site by more than half. See what the company’s director of quality engineering, Dan Buehner, said about it here.

“We’ve reduced the number of open CAPAs that we have by more than 50%, and the things we are opening traditional CAPAs for now are really the things that make sense to, that we should do a deeper dive into.” – Dan Buehner, director of quality engineering, Edwards Lifesciences Corp.

Click here for a free trial of Medtech Insight

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT142984

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel